Also trades as: 3088.T (JPX) · $vol 33M

$14.88

+0.00 (+0.00%)

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 51 · $5.9B mcap · 303M float · 0.0000% daily turnover · Short 90% of daily vol

Revenue

$1.12T +5.9% ▲

5Y CAGR: +15.1%

Gross Profit

$372.5B +0.1% ▲

5Y CAGR: +15.4%

Operating Income

$86.1B +4.9% ▲

5Y CAGR: +22.3%

Net Income

$56.1B +2.7% ▲

5Y CAGR: +21.0%

EPS (Diluted)

$140.61 +5.1% ▲

5Y CAGR: +14.9%

EBITDA

$109.9B +3.2% ▲

5Y CAGR: +21.6%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$730.0B	$951.2B	$1.02T	$1.06T	$1.12T
YoY Growth	+31.1%	+30.3%	+7.5%	+3.8%	+5.9%
Cost of Revenue	$489.7B	$621.9B	$690.7B	$689.4B	$751.9B
Gross Profit	$240.3B	$329.3B	$331.8B	$372.2B	$372.5B
Gross Margin	32.9%	34.6%	32.4%	35.1%	33.1%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$1.7B	$2.1B	$256.1B	$2.2B	$287.1B
Operating Expenses	$198.9B	$267.0B	$278.4B	$290.2B	$286.4B
Operating Income	$41.4B	$62.3B	$75.7B	$82.1B	$86.1B
Operating Margin	5.7%	6.5%	7.4%	7.7%	7.7%
Interest Expense	$60M	$53M	$57M	$64M	$47M
Income Before Tax	$49.6B	$64.9B	$81.2B	$83.9B	$88.6B
Tax Expense	$15.0B	$24.1B	$28.6B	$28.9B	$32.1B
Net Income	$34.4B	$40.5B	$52.3B	$54.7B	$56.1B
Net Margin	4.7%	4.3%	5.1%	5.2%	5.0%
EPS (Diluted)	$93.78	$95.99	$125.27	$133.81	$140.61
EBITDA	$56.3B	$85.8B	$103.7B	$106.6B	$109.9B
Shares Outstanding	417M	422M	418M	409M	399M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$259.7B	$266.0B	$275.8B	$260.1B	$273.6B	$279.4B	$290.5B	$279.9B
Cost of Revenue	$170.5B	$172.9B	$179.6B	$166.4B	$181.0B	$182.4B	$189.9B	$185.6B
Gross Profit	$89.2B	$93.1B	$96.2B	$93.7B	$92.7B	$97.0B	$100.6B	$94.2B
Gross Margin	34.4%	35.0%	34.9%	36.0%	33.9%	34.7%	34.6%	33.7%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$72.0B	$72.7B	$72.2B	$50.7B	$74.5B	$76.1B	$76.7B	$73.4B
Operating Expenses	$72.0B	$72.7B	$72.2B	$73.2B	$72.9B	$76.1B	$76.8B	$72.6B
Operating Income	$17.3B	$20.4B	$24.0B	$20.4B	$19.8B	$20.9B	$23.8B	$21.6B
Operating Margin	6.7%	7.7%	8.7%	7.9%	7.2%	7.5%	8.2%	7.7%
Interest Expense	$14M	$0	$0	$107K	$16M	$19M	$20M	$0
Income Before Tax	$18.5B	$21.0B	$25.1B	$19.3B	$20.7B	$21.9B	$24.9B	$21.0B
Tax Expense	$6.7B	$7.6B	$8.8B	$5.7B	$7.7B	$8.0B	$8.7B	$7.7B
Net Income	$11.7B	$13.3B	$16.3B	$13.5B	$12.9B	$13.8B	$16.1B	$13.3B
Net Margin	4.5%	5.0%	5.9%	5.2%	4.7%	4.9%	5.5%	4.7%
EPS (Diluted)	$27.99	$32.41	$40.28	$33.33	$32.29	$35.00	$40.78	$33.55
EBITDA	$24.0B	$26.0B	$29.6B	$26.1B	$26.3B	$27.7B	$29.8B	$27.9B
Shares Outstanding	417M	410M	404M	404M	401M	398M	398M	398M

MSMKF OTC